Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,316 | -17,826 | -13,074 | -10,213 | -6,433 |
| Depreciation Amortization | 51 | 231 | 170 | 107 | 46 |
| Accounts receivable | N/A | -316 | -195 | -89 | -469 |
| Accounts payable and accrued liabilities | 173 | 399 | 674 | 815 | 171 |
| Other Working Capital | 1,771 | 744 | -86 | 237 | 2,452 |
| Other Operating Activity | 121 | 1,891 | 1,177 | 585 | 910 |
| Operating Cash Flow | $-5,200 | $-14,877 | $-11,334 | $-8,558 | $-3,323 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,300 | 10,248 | 10,111 | 6,766 | 1,300 |
| PPE Investments | -14 | -115 | -115 | -109 | -27 |
| Purchase Of Investment | -2,500 | 2,914 | -1,946 | N/A | N/A |
| Purchase Sale Intangibles | -203 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -70 | 359 | 297 | 115 | 40 |
| Investing Cash Flow | $17,716 | $13,406 | $8,347 | $6,772 | $1,313 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 230 | 1,764 | 1,200 | 1,200 | 1,200 |
| Other Financing Activity | -68 | -252 | -167 | -110 | -55 |
| Financing Cash Flow | $162 | $1,512 | $1,033 | $1,090 | $1,145 |
| Exchange Rate Effect | -31 | -24 | -12 | -11 | -32 |
| Beginning Cash Position | 10,890 | 11,247 | 11,247 | 11,247 | 11,247 |
| End Cash Position | 23,537 | 10,890 | 9,117 | 10,540 | 10,195 |
| Net Cash Flow | $12,647 | $-357 | $-2,130 | $-707 | $-1,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,200 | -14,877 | -11,334 | -8,558 | -3,323 |
| Capital Expenditure | -14 | -115 | -115 | -109 | -27 |
| Free Cash Flow | -5,214 | -14,992 | -11,449 | -8,667 | -3,350 |